Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J A P Daemen

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 4, 2013
The heart and the brain: an intimate and underestimated relationM J A P Daemen
Current Pharmaceutical Design|April 14, 2007
Animal models to study plaque vulnerabilityK Schapira, S Heeneman, M J A P Daemen
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatmentC de Zwaan, M J A P Daemen, W Th Hermens
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 2006
Genome-wide expression studies of atherosclerosis: critical issues in methodology, analysis, interpretation of transcriptomics dataA P J J Bijnens, E Lutgens, T Ayoubi, et al.
The Journal of Pathology|June 24, 2008
Genetic loss of Gas6 induces plaque stability in experimental atherosclerosisE Lutgens, M Tjwa, P Garcia de Frutos, et al.
Journal of Vascular Research|January 17, 2004
Changes in vascular distensibility during angiotensin-converting enzyme inhibition involve bradykinin type 2 receptorsWendy M Aartsen, R H P Hilgers, P M H Schiffers, et al.
Clinical and Experimental Immunology|September 10, 2008
Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L miceM L F Smook, M van Leeuwen, P Heeringa, et al.
Atherosclerosis|December 20, 2005
Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular diseaseM B I Lobbes, E Lutgens, S Heeneman, et al.
The Journal of Pathology|June 19, 2007
Disruption of hedgehog signalling in ApoE - /- mice reduces plasma lipid levels, but increases atherosclerosis due to enhanced lipid uptake by macrophagesL Beckers, S Heeneman, L Wang, et al.
Atherosclerosis|July 9, 2005
Leukocyte CD40L deficiency affects the CD25(+) CD4 T cell population but does not affect atherosclerosisM L F Smook, P Heeringa, J G M C Damoiseaux, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 4, 2013
The heart and the brain: an intimate and underestimated relationM J A P Daemen
Current Pharmaceutical Design|April 14, 2007
Animal models to study plaque vulnerabilityK Schapira, S Heeneman, M J A P Daemen
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatmentC de Zwaan, M J A P Daemen, W Th Hermens
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 2006
Genome-wide expression studies of atherosclerosis: critical issues in methodology, analysis, interpretation of transcriptomics dataA P J J Bijnens, E Lutgens, T Ayoubi, et al.
The Journal of Pathology|June 24, 2008
Genetic loss of Gas6 induces plaque stability in experimental atherosclerosisE Lutgens, M Tjwa, P Garcia de Frutos, et al.
Journal of Vascular Research|January 17, 2004
Changes in vascular distensibility during angiotensin-converting enzyme inhibition involve bradykinin type 2 receptorsWendy M Aartsen, R H P Hilgers, P M H Schiffers, et al.
Clinical and Experimental Immunology|September 10, 2008
Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L miceM L F Smook, M van Leeuwen, P Heeringa, et al.
Atherosclerosis|December 20, 2005
Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular diseaseM B I Lobbes, E Lutgens, S Heeneman, et al.
The Journal of Pathology|June 19, 2007
Disruption of hedgehog signalling in ApoE - /- mice reduces plasma lipid levels, but increases atherosclerosis due to enhanced lipid uptake by macrophagesL Beckers, S Heeneman, L Wang, et al.
Atherosclerosis|July 9, 2005
Leukocyte CD40L deficiency affects the CD25(+) CD4 T cell population but does not affect atherosclerosisM L F Smook, P Heeringa, J G M C Damoiseaux, et al.
Pageof 3